List of investigational analgesics Keratinocyte growth factor Neurotrophic factor receptor Growth factor receptor inhibitor Tyrosine kinase inhibitor GDNF family of ligands Fibroblast growth factor Growth factor receptor Ramucirumab Ephrin Icrucumab Becaplermin Figitumumab Duligotuzumab Mirvetuximab soravtansine Rilotumumab Onartuzumab Ertumaxomab Neuregulin Ciliary neurotrophic factor receptor Robatumumab FGF16 FGF20 IGF-1 LR3 Ficlatuzumab Teprotumumab Emibetuzumab Imgatuzumab Pertuzumab/trastuzumab/hyaluronidase Cerebrolysin FGF15/19 Insulin-like growth factor-binding protein Flanvotumab Dalotuzumab Amivantamab Mecasermin rinfabate Faricimab Hemopoietic growth fa…

actor Platelet-derived growth factor FGF15 Fulranumab Futuximab Alacizumab pegol FGF22 Palifermin Matuzumab Ancestim Neurotrophin Trafermin Necitumumab Angiopoietin Nimotuzumab Cenegermin BNN-20 Adult neurogenesis Evinacumab R13 (drug) Norwogonin FGF11 Anti-VEGF Patritumab Pertuzumab Des(1-3)IGF-1 Neurotrophic factors Trastuzumab/hyaluronidase Seribantumab Tovetumab Dusigitumab Semaxanib Bevacizumab Trk receptor Cetuximab Eutropoflavin LM22A-4 Brolucizumab Cixutumumab Persephin Ganitumab GFRα Neurturin Zalutumumab Fasi

numab Nesvacumab HIOC Motesanib Cediranib ANA-12 Dihexa Vascular endothelial growth factor Fruquintinib Trofinetide IGFBP7 RTK class III 7,8,3'-Trihydroxyflavone Glia maturation factor Grandinin Mecasermin Selpercatinib Nilotinib Asciminib Brigatinib Binimetinib Rociletinib Pralsetinib Olmutinib Tyrosine kinase Receptor activity-modifying protein Linsitinib Renalase Tepotinib Neratinib Trastuzumab emtansine Epigen Olaratumab R7 (drug) Panitumumab Ranibizumab Trastuzumab Trametinib Avapritinib Neuregulin 4 Tavilermide Ephrin receptor IGFBP6 Growth factor Tivozanib Pemigatinib Nintedanib Lenvatinib Ephrin A4 Bosutinib Tesevatinib Capmatinib Erlotinib GFRA3 Ephrin A3 Repotrectinib Radotinib Tucatinib Cabozantinib K252a Foretinib Somatome